Cushing’s syndrome: a model for sarcopenic obesity

• DOI: 10.1007/s12020-017-1370-x
• Publication Date: 2017-07-12T14:59:57Z
• Authors: Michael Drey; Christina M. Berr; Martin Reincke; Julia Fazel; Jochen Seissler; Jochen Schopohl; Martin Bidlingmaier; Stefanie Zopp; Nicole Reisch; Felix Beuschlein; Andrea Osswald; Ralf Schmidmaier
• Keywords: Adult; Male; Sarcopenia; Matched-Pair Analysis; 10265 Clinic for Endocrinology and Diabetology; 610 Medicine & health; Models, Biological; Body Mass Index; 03 medical and health sciences; 0302 clinical medicine; Germany; Glucose Intolerance; Humans; Obesity; Prospective Studies; Muscle, Skeletal; Propensity Score; Cushing Syndrome; Glycated Hemoglobin; 2. Zero hunger; Sarcopenic obesity; Frailty; Hand Strength; Middle Aged; 1310 Endocrinology; 3. Good health; 2712 Endocrinology, Diabetes and Metabolism; Cushing’s syndrome; Body Composition; Female; Insulin Resistance; Biomarkers

Obesity and its metabolic impairments are discussed as major risk factors for sarcopenia leading to sarcopenic obesity. Cushing's syndrome is known to be associated with obesity and muscle atrophy. We compared Cushing's syndrome with matched obese controls regarding body composition, physical performance, and biochemical markers to test the hypothesis that Cushing's syndrome could be a model for sarcopenic obesity.By propensity score matching, 47 controls were selected by body mass index and gender as obese controls. Fat mass and muscle mass were measured by bioelectrical impedance analysis. Muscle function was assessed by chair rising test and hand grip strength. Biochemical markers of glucose and lipid metabolism and inflammation (hsCRP) were measured in peripheral blood.Muscle mass did not differ between Cushing's syndrome and obese controls. However, Cushing's syndrome patients showed significantly greater chair rising time (9.5 s vs. 7.3 s, p = 0.008) and significantly lower hand grip strength (32.1 kg vs. 36.8 kg, p = 0.003). Cushing's syndrome patients with impaired fasting glucose have shown the highest limitations in hand grip strength and chair rising time.Similar to published data in ageing medicine, Cushing's syndrome patients show loss of muscle function that cannot be explained by loss of muscle mass. Impaired muscle quality due to fat infiltration may be the reason. This is supported by the observation that Cushing's syndrome patients with impaired glucose metabolism show strongest deterioration of muscle function. Research in sarcopenic obesity in elderly is hampered by confounding comorbidities and polypharmacy. As Cushing's syndrome patients are frequently free of comorbidities and as Cushing's syndrome is potentially curable we suggest Cushing's syndrome as a clinical model for further research in sarcopenic obesity.